Alpha-Lipoic Acid and Metformin Combination Therapy Synergistically Activate Nrf2-AMPK Signaling Pathways to Ameliorate Cognitive Dysfunction in Type 2 Diabetic Encephalopathy: A Preclinical Study
Diabetic encephalopathy affects over 40% of diabetic patients globally, yet effective treatments remain critically limited. This study investigated the synergistic neuroprotective potential of alpha-lipoic acid (ALA) and metformin through the coordinated activation of Nrf2 and AMPK signaling pathway...
Saved in:
| Main Authors: | Abdulmajeed F. Alrefaei, Mohamed E. Elbeeh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-7737/14/7/885 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin and berberine synergistically improve NAFLD via the AMPK–SREBP1–FASN signaling pathway
by: Na Li, et al.
Published: (2025-08-01) -
Involvement of NRF2 and AMPK signaling in aging and progeria: a digest
by: Eleni Petsouki, et al.
Published: (2025-09-01) -
Cellular and molecular mechanisms of alpha lipoic acid’s protective effects against diclofenac-induced hepatorenal toxicity
by: Ogaly Hanan A., et al.
Published: (2025-05-01) -
Acrolein-Triggered Ferroptosis and Protection by Intermittent Fasting via the AMPK/NRF2-CLOCK/BMAL1 Pathway
by: Yuandie Zhang, et al.
Published: (2025-05-01) -
Fucoidan protects against LPS-induced mastitis and enhances the integrity of blood-milk barrier by activating AMPK/Nrf2 and autophagy
by: Xiaoben Liang, et al.
Published: (2025-02-01)